Literature DB >> 26560117

Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development.

Satoshi Sakai1, Chiharu Miyajima, Chiharu Uchida, Yuka Itoh, Hidetoshi Hayashi, Yasumichi Inoue2.   

Abstract

Tribbles-related protein (TRB) family members are the mammalian orthologs of Drosophila tribbles. Tribbles was originally identified as a cell cycle regulator during Drosophila development. Tribbles genes are evolutionary conserved, and three TRB genes (TRB1, TRB2 and TRB3) have been identified in mammals. TRBs are considered pseudokinases because they lack an ATP binding site or one of the conserved catalytic motifs essential for kinase activity. Instead, TRBs play important roles in various cellular processes as scaffolds or adaptors to promote the degradation of target proteins and to regulate several key signaling pathways. Recent research has focused on the role of TRBs in tumorigenesis and neoplastic progression. In this review, we focus on the physiological roles of TRB family members in tumorigenesis through the regulation of the ubiquitin-proteasome system and discuss TRBs as biomarkers or potential therapeutic targets in cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26560117     DOI: 10.2174/1568009616666151112122645

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  10 in total

1.  Governing roles for Trib3 pseudokinase during stress erythropoiesis.

Authors:  Arvind Dev; Ruth Asch; Edward Jachimowicz; Nicole Rainville; Ashley Johnson; Emily Greenfest-Allen; Don M Wojchowski
Journal:  Exp Hematol       Date:  2017-01-04       Impact factor: 3.084

2.  Tribbles pseudokinase NIPI-3 regulates intestinal immunity in Caenorhabditis elegans by controlling SKN-1/Nrf activity.

Authors:  Chenggang Wu; Ozgur Karakuzu; Danielle A Garsin
Journal:  Cell Rep       Date:  2021-08-17       Impact factor: 9.423

3.  TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling.

Authors:  Zhenlin Hou; Kaixuan Guo; Xuling Sun; Fuqing Hu; Qianzhi Chen; Xuelai Luo; Guihua Wang; Junbo Hu; Li Sun
Journal:  Mol Cancer       Date:  2018-12-12       Impact factor: 27.401

4.  TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.

Authors:  Baoan Hong; Jingcheng Zhou; Kaifang Ma; Jiufeng Zhang; Haibiao Xie; Kenan Zhang; Lei Li; Lin Cai; Ning Zhang; Zhongyuan Zhang; Kan Gong
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

5.  Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein.

Authors:  Yue Zhu; Jie Cui; Jiatao Liu; Wei Hua; Wei Wei; Guoping Sun
Journal:  Cancer Med       Date:  2020-03-11       Impact factor: 4.452

6.  miR-509-5p Inhibits the Proliferation and Invasion of Osteosarcoma by Targeting TRIB2.

Authors:  Jiekun Guo; Qiang Wu; Xiaoming Peng; Bin Yu
Journal:  Biomed Res Int       Date:  2019-12-16       Impact factor: 3.411

7.  Tribbles Pseudokinase 2 (TRIB2) Regulates Expression of Binding Partners in Bovine Granulosa Cells.

Authors:  Aly Warma; Jacques G Lussier; Kalidou Ndiaye
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 8.  The Critical Role of TRIB2 in Cancer and Therapy Resistance.

Authors:  Victor Mayoral-Varo; Lucía Jiménez; Wolfgang Link
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

Review 9.  Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway.

Authors:  Naoki Inui; Satoshi Sakai; Masatoshi Kitagawa
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

10.  TRIB2 Stimulates Cancer Stem-Like Properties through Activating the AKT-GSK3β-β-Catenin Signaling Axis.

Authors:  Dae Kyoung Kim; Yu Na Kim; Ye Eun Kim; Seo Yul Lee; Min Joo Shin; Eun Kyoung Do; Kyung-Un Choi; Seung-Chul Kim; Ki-Hyung Kim; Dong-Soo Suh; Parkyong Song; Jae Ho Kim
Journal:  Mol Cells       Date:  2021-07-31       Impact factor: 5.034

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.